New diabetes clinical trial: Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE

Published on: November 25, 2024 at 11:00PM
Conditions: Eosinophilic Esophagitis
Interventions: Biological: Dupilumab; Drug: Fluticasone
Sponsors: University of Colorado, Denver; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/b0DC89Q

Comments